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Conclusions Arteriovenous fistula is a quite frequent com-
plication of native renal biopsy and can cause ischemia in 
the renal parenchyma detected by ultrasound. The arteries 
supplying the fistula are characterized by an increased flow 
velocity and reduced resistance index.
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Introduction
Percutaneous renal biopsy (PRB) is an essential tool in the 
diagnosis of diseases of the native and transplanted kidneys. 
The progress made in recent years, both in terms of biopsy 
devices, ultrasound techniques and equipment and the pos-
sibility of endovascular treatment, significantly improved 
safety of this procedure [1, 2]. Due to the technique and the 
ultrasound equipment necessary to monitor the procedure, 
in some centers, instead of nephrologists, PRB is more and 
more often performed by radiologists [3]. Clinical monitor-
ing of a patient after PRB without radiological imaging as 
well as radiological approach without clinical data results 
in a significant discrepancy in the reported complications. 
In view of the fact that nearly 98 % of PRB complications 
occur within 24 h after the procedure and only 46 % after 
4 h and 79 % after 8 h, it is recommended to monitor the 
patient until the next day [4]. One of the complications 
of PRB is an abnormal shunting of blood from the artery 
to the vena in the vicinity of the biopsy channel, namely 
post-biopsy arteriovenous fistula (RB-AVF). Generally, a 
majority of observed fistulas are clinically asymptomatic 
and close spontaneously. This fact, together with ignoring 
the diagnostic ultrasound or discontinuation of the use of 
the color Doppler (CD) imaging in clinically silent cases, 
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contributes to reducing the incidence of RB-AVF. On the 
other hand, some sources report significant clinical compli-
cations in as many as 20–41 % of RB-AVF cases and the 
necessity of invasive treatment [5].
The aim of the study was to prospectively evaluate the 
incidence of RB-AVF in native kidneys, together with the 
assessment of hemodynamic characteristics and the impact 
of the histopathological results of biopsy.
Methods
From 172 consecutive patients who underwent percutane-
ous renal biopsy of native kidneys in the period from Janu-
ary 2012 to March 2016 (51 months) in the Department of 
Nephrology, 138 Caucasian patients (age 46.2 ± 15.2; 70 
F, 68 M) were qualified to the prospective observational 
study. The involved patients were monitored after PRB by 
ultrasound for the occurrence of iatrogenic arteriovenous 
fistula associated with PRB. The study was conducted in 
accordance with the Declaration of Helsinki. All partici-
pants enrolled in the study gave informed consent.
PRB was performed in patients previously qualified by 
an experienced nephrologist, with correct results of acti-
vated partial thromboplastin time (aPTT), international 
normalized ratio (INR), platelet count >100000/ml and 
blood pressure below RR 140/90 mmHg, without focal 
lesions in the lower pole of the left kidney in ultrasound 
examination. If used, all antiplatelets and anticoagulants 
were discontinued 7 days before the biopsy, except for low 
molecular weight heparin, administered not later than 24 h 
before the PRB.
Biopsies in the lower pole of the left kidney were per-
formed by the same experienced team composed of neph-
rologist performing hands-free PRB with a radiologist 
showing real-time USG image and tracking of the needle. 
Automated devices (BARD MAGNUM Reusable Core 
Biopsy System, C.R BARD Inc.) with a 14-gauge and 
16 cm long needle with a penetration depth of 22 mm were 
employed for renal biopsy.
Prior to the biopsy, an assigned channel for needle tra-
jectory was anesthetized locally from the skin surface to 
the kidney capsule with a 2 % lignocaine solution. During 
the PRB, only one biopsy needle pass was performed.
Immediately after the biopsy, a compressive band-
age was applied on the left lumbar area; then, the patient 
remained in the supine position for the next 24 h, with a 
roll on the left lumbar region for the first 4 h after PRB.
Ultrasound examinations of the left kidney (Logiq P6, 
Convex 3.5–5 MHz) were performed by only one inde-
pendent and always the same ultrasound specialist after 
approximately 24 h after PRB. Left kidney and the peri-
renal area were visualized in 2D using posterolateral or 
the left lumbar area access, in the longitudinal and trans-
verse plane. Color Doppler and power Doppler options 
were employed for the flow diagnosis in the observed 
hematomas.
For the diagnosis of PRB-related iatrogenic arterio-
venous fistula, in CD imaging intrarenal arteries were vis-
ualized in the renal sinus and parenchyma in longitudinal 
sections. Then, CD velocity was gradually increased until 
no flow signal in the most of previously visualized intra-
renal arteries was observed. Identification of high-intensity 
flow in one or one of several other vessels raised a suspi-
cion of arteriovenous fistula (Fig. 1). In order to confirm 
the RB-AVF, maximal flow velocity (FV) and resistance 
index (RI) were measured in the segmental artery feeding 
the fistula and in the segmental artery of the middle part or 
of the upper pole of the left kidney, depending on the pos-
sibilities to visualize vessels (Fig. 2).
In the case of ultrasonographic characteristics of RB-
AVF, patients were monitored during consecutive days of 
the same hospitalization, and in the course of subsequent 
hospitalizations if possible.
Fig. 1  Renal biopsy-related arteriovenous fistulas detected in color 
Doppler
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Collected in renal biopsies, tissue specimens were his-
tologically evaluated. The number of the glomeruli in each 
biopsy was counted. For quantitative evaluation of intersti-
tial inflammatory infiltration, interstitial fibrosis, tubular 
atrophy, arterial narrowing and hyalinosis, the recommen-
dations of the Banff classification were used [6, 7].
Statistical analysis
The examined variables were analyzed with Pearson’s or 
Spearman’s correlation test as determined by meeting the 
condition of normal distribution. The t test and U Mann–
Whitney test were used to analyze the difference between 
the groups. Receiver operating characteristic (ROC) analy-
sis was performed to assess a prognostic value of glomeruli 
number and maximal hematoma diameter in recognizing 
renal biopsy-related arteriovenous fistula. For statistical 
analysis, Statistica 12 (StatSoft Inc.) software was used.
Results
Among 138 PRB, bleeding complications in the form of 
perirenal and subcapsular hematomas were found in 136 
patients (98.55 %). The mean of maximal hematoma diam-
eter was 36.7 ± 21.3 mm.
We observed 7 cases (0.051 %) of additional hemato-
mas in the perirenal area or in the left iliopsoas muscle, 
2 cases (0.015 %) of enlarging hematomas in subsequent 
examinations (including one with RB-AVF), without signs 
of an active bleeding, and 1 (0.007 %) active retroperito-
neal hemorrhage with forming a pseudoaneurysm, which 
required an endovascular invasive treatment.
In the analyzed material of 138 biopsies, a total of 23 
RB-AVF cases (16.67 %) were found. Groups with and 
without RB-AVF did not differ significantly in terms of 
studied demographic, biochemical and morphological data 
(Table 1). The maximal hematoma diameter was signifi-
cantly longer in the RB-AVF group (p = 0.005).
Compared to the PRB without a fistula, RB-AVF group 
had a significantly lower number of renal glomeruli in 
biopsy samples (p = 0.015) (Table 2). Other results of renal 
biopsy did not differ significantly between the groups.
In the evaluated material, Doppler study showed 
that flow velocities were significantly higher, and RI 
Fig. 2  Doppler hemodynamic assessment of renal biopsy-related 
arteriovenous fistulas
Table 1  Comparison of 
demographic, biochemical and 
2D ultrasound data between 
groups with and without renal 
biopsy-related arteriovenous 
fistula
a  Median [range]
RB-AVF (n = 23) PRB without fistula (n = 115) p value
Age (years) 40.5 ± 14.7 47.2 ± 15.1 0.058
BMI (kg/m2) 25.3 ± 4.5 26.7 ± 4.5 0.165
Creatinine (mg/dl) 1.60 ± 1.51 1.67 ± 1.18 0.319
Proteinuria (g/24 h)a 1.60 [0.13–13.4] 3.16 [0.00–29.50] 0.073
Renal length (mm) 117.5 ± 5.2 116.0 ± 13.1 0.696
Parenchymal thickness 16.3 ± 2.9 16.0 ± 3.2 0.750
Maximal hematoma diameter (mm) 48.7 ± 23.9 34.5 ± 19.9 0.005
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significantly lower in arteries supplying the fistula com-
pared to the other segmental arteries of the left kidney 
(Table 3). The mean difference in FV was 45.9 cm/sec and 
in RI 0.252. In the ROC analysis, RI of 0.524 allowed for 
recognizing RB-AVF with a sensitivity of 91 % and a spec-
ificity of 100 % (AUC 0.998, p < 0.001) and was a better 
predictor of this complication (p < 0.001) than maximum 
flow velocity (sensitivity 80 %; specificity 89.5 % for FV 
60.9 cm/s; AUC 0.900, p < 0.001).
In approximately 39 % of cases (9/23), ultrasound 
found a conical hyperechogenic area with a mean size of 
12.2 × 17.6 mm in the vicinity of the observed arterio-
venous fistula (Fig. 3).
In the correlation analysis, regarding demographic, bio-
chemical, ultrasound and histopathological results, only 
the number of glomeruli (r = −0.22) and the maximal 
hematoma diameter after PRB (r = 0.24) were signifi-
cantly associated with RB-AVF (p < 0.05). Age, weight, 
BMI, kidney size, renal parenchymal thickness and creati-
nine were not associated with the development of the RB-
AVF. In the ROC analysis, a number of glomeruli equal to 
10 was associated with the occurrence of RB-AVF with a 
sensitivity of 60 % and a specificity of 67 % (AUC 0.673, 
p = 0.009), while the maximal hematoma diameter of 
34 mm allowed for the identification of RB-AVF with a 
sensitivity of 65 % and a specificity of 60 % (AUC 0.686, 
p = 0.002).
In 12 cases (52 %), the persistence of arteriovenous fis-
tula for more than 1 day was observed. The median of the 
period in which the presence of the fistula was found in 
these patients was 2 days (range 2–26 days after PRB). In 
9 patients (39 %), of whom only four patients had RB-AVF 
for more than 1 day, the next study showed no presence of 
the fistula, and the median of the period from PRB to the 
examination was 3 days (range 2–42 days). Five patients 
with diagnosed asymptomatic RB-AVF were discharged 
from the hospital and did not report for the further study.
Discussion
In the available literature, the main factors increasing the 
risk of serious complications after PRB include, inter alia, 
elevated creatinine concentration, systolic and diastolic 
blood pressure values, decreased hemoglobin concentra-
tion, coagulation disorders, the thickness of the biopsy nee-
dle (16 or 18 gauge instead of 14 gauge) and the lack of 
use of ultrasound-guided needle [1, 8]. Based on previous 
reports, it is believed that the number of serious bleeding 
complications requiring transfusion is 0.3–7.4 % and minor 
complications (small hematomas, arteriovenous fistulas, 
transient hematuria) 1–92 % [9, 10]. Significant discrep-
ancies in the described complications reported by various 
authors probably result from the different nature of the 
studies and different diagnostic criteria [1]. For instance, 
Waldo et al. [11] reported only clinically symptomatic 
hematomas, but of the maximal diameter under 1 cm, 
while Hergesell et al. [12] considered small hematomas 
only from 2 × 2 cm upwards. On the basis of renal biopsy 
performed in 50 children, Riccabona et al. [9] found the 
occurrence of post-biopsy hematomas with the incidence 
of 92 % and arteriovenous fistulas with 12 %. Based on 
our prospective evaluation, we proved that PRB bleeding 
complications are present in a majority of procedures, but 
are clinically insignificant. In the ultrasound of 138 kidneys 
after the PRB using a 14-gauge biopsy needle, we found 
the presence of hematomas in up to 98.5 %. Although in 
our study most patients had hemorrhagic complications in 
Table 2  Comparison of renal biopsy findings between groups with 
and without renal biopsy-related arteriovenous fistula
RB-AVF renal biopsy-related arteriovenous fistula, RB renal biopsy
a Median [range]
RB-AVF PRB without fistula p value
Number of glomeruli 11.9 ± 7.1 16.9 ± 9.6 0.015
Interstitial inflammationa 1 [0–4] 2 [0–4] 0.511
Interstitial fibrosisa 2 [0–4] 2 [0–4] 0.599
Tubular atrophya 2 [0–4] 2 [0–4] 0.725
Arterial narrowinga 1 [0–3] 1 [0–3] 0.714
Arterial hyalinosisa 0 [0–4] 0 [0–4] 0.469
Table 3  Results of Doppler 
study on renal biopsy-related 
arteriovenous fistulas
RB-AVF renal biopsy-related arteriovenous fistula, RI resistive index, dRI the difference between resistive 
indexes in normal and feeding arteriovenous fistula segmental arteries, FV maximal flow velocity, dFV the 
difference between maximal flow velocities in feeding arteriovenous fistula and normal segmental arteries
a Median [range]
Normal renal segmental artery Renal segmental artery  
supplying RB-AVF
p value
RI 0.673 ± 0.052 0.439 ± 0.069 <0.001
FV (cm/s) 43.43 ± 12.15 86.25 ± 31.92 <0.001
dRIa 0.252 ± 0.104 [range 0.132–0.615] –
dFV (cm/s)a 45.9 ± 20.0 [range 4.0–97.9] –
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the form of subscapular or perirenal hematoma after PRB, 
only 9 cases (6.5 %) required prolonged hospitalization 
and further noninvasive diagnostic procedures. In addition, 
only one patient (0.007 %) with an active retroperitoneal 
hemorrhage with forming a pseudoaneurysm required an 
endovascular invasive treatment. Moreover, in only one 
patient the occurrence of arteriovenous fistula was in rela-
tion with hematoma enlargement in subsequent examina-
tions. These data confirm that the procedure of percutane-
ous renal biopsy is quite safe. On the other hand, there are 
data suggesting a greater safety of ultrasound-guided PRB 
than real-time ultrasound-assisted (hands-free) PRB [2, 8].
The presence of an arteriovenous fistula which com-
plicates PRB both can be clinically insignificant and, 
in extreme cases, can cause serious hemorrhage, resist-
ant hypertension, renal or heart failure [5, 10, 13]. The 
incidence of fistulas after PRB of native kidneys is esti-
mated to be approximately 7.4–9 % and 8.3–16.6 % for 
transplanted kidneys, with approximately 1 of 5 RB-AVF 
is symptomatic [10, 12, 14, 15]. However, it should be 
mentioned that the transplanted kidney is easily accessible 
by ultrasound, and PRBs are often performed repeatedly 
in the same kidney. In our work, we proved a higher inci-
dence of RB-AVF in native kidneys in comparison with 
the reports of other authors. The reason for this is probably 
the prospective nature of our study and the applied pro-
tocol assuming an active search for arteriovenous fistula 
after PRB. The incidence of RB-AVF in our study is com-
parable with the results reported in transplanted kidneys. 
Nevertheless, in the presented study, we could not identify 
any risk factors for the development of RB-AVF because 
it was not associated with age, weight, BMI, kidney size, 
renal parenchymal thickness or even with the creatinine 
concentration.
Although in the available literature, there are case reports 
on hemodynamic properties of RB-AVF, our work shows 
this characteristics on a significantly larger group. Based on 
the performed observations, we found an average twofold 
increase in the maximum flow velocity and RI decrease of 
approximately 35 % in the segmental arteries supplying 
the fistula. RI value ≤0.524 in the segmental artery was 
the best predictor of RB-AVF (sensitivity 91 %, specificity 
100 %). Although Yokoyama et al. [16] observed the use-
fulness of ultrasound in detecting RB-AVF, they suggested 
it should be confirmed in CT. Schwarz et al. [14] examin-
ing RB-AVF in transplanted kidneys suggested recognition 
of hemodynamic relevance of this complication when the 
difference between RI in the renal artery and RI in the seg-
mental artery not associated with RB-AVF does not exceed 
0.05. In our observation, in all arteries supplying the fistula, 
RI was at least 0.1 lower compared to normal segmental 
arteries, which, together with the described by us technique 
for detection in color Doppler and qualitative assessment of 
turbulent flow, can be considered as a useful criterion for 
recognizing RB-AVF. Our results significantly expand the 
reports of other authors who, in ultrasound examination in 
patients with RB-AVF, found both an increase in the flow 
velocity and a decrease in RI in the artery supplying fistula, 
but no diagnostic thresholds have been proposed [9, 10, 
15, 17]. Most similar results of hemodynamic changes in 
RB-AVF were demonstrated by Middleton et al. [18] on the 
example of eight patients, but due to the size of the group 
and the characteristics of the equipment at that time, the 
data may be partly misleading.
In the presented study, ultrasound examinations were 
performed by only one and always the same experienced 
ultrasound specialist. Moreover, a single measurement of 
hemodynamic parameters was performed in arteries sup-
plying AVFs as well as in normal segmental arteries. Thus, 
the assessment of interobserver and intraobserver vari-
ability was not possible. Based on previous studies, in RI 
measurements taken by well-trained staff, intraobserver 
variability ranged from 2.07 to 5.1 %, while interobserver 
variability ranged from 3.61 to 6.2 % [19].
Fig. 3  Hyperechogenic area in the neighborhood of the arteriovenous 
fistula
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Performing 2D ultrasound in patients with RB-AVF, in 
approximately 40 % of cases we found the presence of the 
conical hyperechogenic area in the vicinity of the fistula, 
probably resulting from stealing blood by the fistula and 
ischemia in this fragment of parenchyma. To the best of our 
knowledge, this ultrasound phenomenon has not been thus 
far described in the available literature.
Demonstrated in our study, the correlation of fewer glo-
meruli in PRB and, at the same time, larger sizes of bleed-
ing complications in patients with RB-AVF suggests prob-
ably insufficient control of the biopsy site in a hands-free 
procedure, which may result from both the change in the 
direction of the needle at the time of releasing a biopsy 
mechanism. The use of ultrasound-guided biopsy needle 
could probably reduce the incidence of bleeding compli-
cations and increase the diagnostic value of PRB [8]. The 
other, but direct reason for the diminished number of glo-
meruli in RB-AVF patients could be perivascular and vas-
cular area accessed by the biopsy needle.
In the available reports, most RB-AVFs close sponta-
neously. Brandenburg et al. [15], examining RB-AVF in 
transplanted kidneys, observed a spontaneous closure of 
50 % fistulas within 2 days, and 75 % of RB-AVFs dur-
ing 4 weeks. Nevertheless, the authors reported a persis-
tence of 3 fistulas (25 %) for more than 1 year. Our results 
seem to coincide with this report, because although we 
observed a spontaneous closure of RB-AVF after an 
average of 3 days in approximately 40 % of patients, 
five patients (21.7 %) with RB-AVF were not subjected 
to further observation for objective reasons. The above-
mentioned lack of the data does not allow for adequate 
conclusions and is a limitation of our work. Due to the 
fact that most of RB-AVFs are asymptomatic and resolve 
spontaneously, in these cases a follow-up Doppler sono-
gram, about 6 months after renal biopsy, could help in the 
detection of persisting and progressing arteriovenous fis-
tulas [20].
Conclusions
Bleeding complications are observed in most of real-time 
ultrasound-guided native renal biopsies, but in a majority 
of cases, their clinical significance is low. Post-biopsy arte-
riovenous fistulas occur with a similar incidence in native 
and transplanted kidneys. They can cause a local steal 
syndrome corresponding to the fragment of parenchyma, 
detectable in the 2D ultrasound. The arteries supplying the 
fistula are characterized by an increased flow velocity and 
a reduced resistance index, which can be a useful tool in 
the detection of arteriovenous fistulas. Although percuta-
neous renal biopsy still remains a safe procedure and most 
of post-biopsy arteriovenous fistulas are clinically silent, a 
follow-up Doppler sonography in a few months after renal 
biopsy is proposed to discover persisting and progressing 
arteriovenous fistulas.
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